Phytochemical analysis of medicinal plants of Nepal and their antibacterial and antibiofilm activities against uropathogenic Escherichia coli.


Journal

BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232

Informations de publication

Date de publication:
09 Apr 2021
Historique:
received: 27 08 2020
accepted: 30 03 2021
entrez: 10 4 2021
pubmed: 11 4 2021
medline: 25 11 2021
Statut: epublish

Résumé

A biofilm is an extracellular polymeric substance (EPS) composed of polysaccharides, proteins, nucleic acids, and lipids that impede antibiotics and immune cells, thus providing a shielded environment for bacterial growth. Due to biofilm formation, some microbes can show up to 1000 fold increased resistance towards the antibiotics than the normal planktonic forms. The study was conducted to screen the crude extracts of medicinal plants used in Nepal for their in vitro antibiofilm activities. Total phenolic and total flavonoid contents were determined by using a Folin-Ciocalteau reagent and aluminium trichloride method, respectively. Resazurin assay was used to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The initial antibiofilm activities and their inhibitory concentration (IC Out of 25 different plant extracts were used for the study, methanolic extracts of 20 plants showed a biofilm inhibition activity against five different strong biofilm producing Escherichia coli strains. Calotropis gigantea exhibited inhibition against all five different E. coli strains with IC Extracts of C. gigantea, E. prostrata, P. persica, U. parviflora, and O. tenuifolium showed antibacterial as well as antibiofilm activity against pathogenic and strong biofilm producing E. coli. Thus, extracts or the pure compound from these medicinal plants could be used as antibiotics in the future.

Sections du résumé

BACKGROUND BACKGROUND
A biofilm is an extracellular polymeric substance (EPS) composed of polysaccharides, proteins, nucleic acids, and lipids that impede antibiotics and immune cells, thus providing a shielded environment for bacterial growth. Due to biofilm formation, some microbes can show up to 1000 fold increased resistance towards the antibiotics than the normal planktonic forms. The study was conducted to screen the crude extracts of medicinal plants used in Nepal for their in vitro antibiofilm activities.
METHODS METHODS
Total phenolic and total flavonoid contents were determined by using a Folin-Ciocalteau reagent and aluminium trichloride method, respectively. Resazurin assay was used to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The initial antibiofilm activities and their inhibitory concentration (IC
RESULTS RESULTS
Out of 25 different plant extracts were used for the study, methanolic extracts of 20 plants showed a biofilm inhibition activity against five different strong biofilm producing Escherichia coli strains. Calotropis gigantea exhibited inhibition against all five different E. coli strains with IC
CONCLUSION CONCLUSIONS
Extracts of C. gigantea, E. prostrata, P. persica, U. parviflora, and O. tenuifolium showed antibacterial as well as antibiofilm activity against pathogenic and strong biofilm producing E. coli. Thus, extracts or the pure compound from these medicinal plants could be used as antibiotics in the future.

Identifiants

pubmed: 33836728
doi: 10.1186/s12906-021-03293-3
pii: 10.1186/s12906-021-03293-3
pmc: PMC8033659
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116

Références

Appl Environ Microbiol. 2005 Jul;71(7):4022-34
pubmed: 16000817
Lancet. 2001 Jul 14;358(9276):135-8
pubmed: 11463434
Biomed Res Int. 2013;2013:510736
pubmed: 24386637
Chin Med. 2019 Mar 20;14:11
pubmed: 30936939
Chem Rev. 2011 Jan 12;111(1):28-67
pubmed: 21182299
Phytomedicine. 2006 Mar;13(4):261-6
pubmed: 16492529
ScientificWorldJournal. 2017;2017:5873648
pubmed: 28386582
Ann Clin Microbiol Antimicrob. 2019 Dec 17;18(1):42
pubmed: 31847837
Clin Microbiol Rev. 1999 Oct;12(4):564-82
pubmed: 10515903
Food Chem. 2011 Nov 15;129(2):637-644
pubmed: 30634280
J Antimicrob Chemother. 2008 Oct;62(4):751-7
pubmed: 18565974
Molecules. 2016 Dec 13;21(12):
pubmed: 27983597
Antimicrob Agents Chemother. 2009 Jan;53(1):216-22
pubmed: 18573934
APMIS Suppl. 2013 May;(136):1-51
pubmed: 23635385
Evid Based Complement Alternat Med. 2016;2016:1572697
pubmed: 27429633
Annu Rev Microbiol. 1995;49:711-45
pubmed: 8561477
Pharm Biol. 2013 Jun;51(6):728-36
pubmed: 23577802
Int J Med Microbiol. 2002 Jul;292(2):107-13
pubmed: 12195733
Antimicrob Agents Chemother. 2009 Jun;53(6):2432-43
pubmed: 19364871
Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S85-8
pubmed: 17582577
BMC Complement Altern Med. 2019 Jun 20;19(1):141
pubmed: 31221162
Prog Drug Res. 1991;37:91-105
pubmed: 1763187
Methods. 2007 Aug;42(4):321-4
pubmed: 17560319
Ann Clin Microbiol Antimicrob. 2014 Aug 19;13:40
pubmed: 25135359
J Agric Food Chem. 2009 Jul 22;57(14):5987-6000
pubmed: 19548681
New Microbes New Infect. 2015 Feb 12;8:166-70
pubmed: 27257498
J Appl Microbiol. 2010 Aug;109(2):515-27
pubmed: 20163489
Biotechnol Lett. 2016 Jun;38(6):1015-9
pubmed: 26969604
Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007
pubmed: 11257008
BMC Complement Altern Med. 2017 Jun 26;17(1):337
pubmed: 28651570
Nat Protoc. 2007;2(4):875-7
pubmed: 17446889
Int J Food Microbiol. 2014 Mar 17;174:47-55
pubmed: 24457153
Biofouling. 2013;29(10):1189-203
pubmed: 24067082
J Agric Food Chem. 2012 Apr 11;60(14):3792-9
pubmed: 22397498
J Food Drug Anal. 2014 Sep;22(3):296-302
pubmed: 28911418
J Intern Med. 2012 Dec;272(6):541-61
pubmed: 23025745
Indian J Med Res. 2016 May;143(5):643-51
pubmed: 27488009
Anim Biotechnol. 2006;17(2):111-24
pubmed: 17127523
Future Microbiol. 2012 Sep;7(9):1061-72
pubmed: 22953707
Curr Opin Chem Biol. 2003 Oct;7(5):586-91
pubmed: 14580562
J Appl Microbiol. 2012 Aug;113(2):438-47
pubmed: 22563853
Appl Environ Microbiol. 2004 Dec;70(12):6951-6
pubmed: 15574886
Int J Antimicrob Agents. 2012 Feb;39(2):124-9
pubmed: 22079533
Trends Microbiol. 2005 Jan;13(1):34-40
pubmed: 15639630
Wound Repair Regen. 2012 Mar-Apr;20(2):125-36
pubmed: 22380687
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
Lett Appl Microbiol. 2010 Jan;50(1):30-5
pubmed: 19874481
J Conserv Dent. 2015 Nov-Dec;18(6):457-60
pubmed: 26752839
J Tradit Complement Med. 2016 Jul 12;7(2):172-177
pubmed: 28417087
APMIS. 2010 Nov;118(11):873-7
pubmed: 20955460
Curr Opin Microbiol. 2011 Oct;14(5):556-63
pubmed: 21802347

Auteurs

Sudip Bhandari (S)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Karan Khadayat (K)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Sami Poudel (S)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Sunil Shrestha (S)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Raju Shrestha (R)

Department of Microbiology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Poonam Devkota (P)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Santosh Khanal (S)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal.

Bishnu P Marasini (BP)

Department of Biotechnology, National College, Tribhuvan University, Naya Bazar, Kathmandu, Nepal. bishnu.marasini@gmail.com.

Articles similaires

Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol
Female Biofilms Animals Lactobacillus Mice

Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agents.

Doris Crnčević, Alma Ramić, Andreja Radman Kastelic et al.
1.00
Humans Microbial Sensitivity Tests Anti-Bacterial Agents Biofilms Quinuclidines
Biofilms Horses Animals Escherichia coli Mesenchymal Stem Cells

Classifications MeSH